Sana Biotechnology

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, South San Francisco, and Rochester.

  • NextGen Class of 2021
  • 2023 Best Places to Work
  • 2024 Best Places to Work
188 East Blaine Street, Suite 400
Seattle, WA 98102
  • Featured Employer Badge

We never lose sight of why our work matters – the potential to impact the lives of patients is important to everyone at Sana.

As we push the bounds of scientific discovery, we recognize there will be obstacles and setbacks, but we remain resilient in pursuit of our mission. We are looking for relentless individuals to join us and make this big vision a reality.

Our values are what ground us, keep our team connected, and make it possible for us to do our best work.

Lead from every seat.

We have a humble and unrelenting commitment to deliver for patients and our community – we seek to understand, act with honesty, and engage in the crucial conversations.

Thrive as a team.

We make each other better than we ever thought possible – we hire amazing people, are intensely curious, and cultivate inclusion and personal connectivity.

Make it happen.

We make great choices with urgency and integrity – we value vigorous debate, alignment around our decisions, and resilient execution.

At Sana, we believe that a diverse workforce strengthens us as a company and a community, which is essential for us to meaningfully change outcomes for patients across a wide range of diseases. We strive daily to make Sana an inclusive environment that attracts diverse talent and enables all people to thrive. Inclusion, diversity, and equity are key pillars in our overall strategy.

One of our core cultural tenets is that we make each other better than we ever thought possible. We want Sana to be the place for uniquely talented people to bring their authentic selves to work with an equal opportunity to make an impact, develop their careers, and deeply and positively impact the lives of patients.

Learn more about our IDE Approach.

Sana is proud to offer comprehensive benefits programs to our valued employees and their eligible loved ones. We thoughtfully design our programs, coverage, and guidelines with the needs of our employees in mind. Our goal is to make available a diverse offering of health and well-being resources and support so that employees can thrive and do the best work of their lives.

Learn more about Sana’s Benefits.

Sana Scholars is our internship and co-op program, seeking students who share in our passion for developing engineered cells as medicines and who believe that they have the potential to meaningfully change outcomes for patients across a broad swath of diseases. Sana Scholars also believe that building an inclusive, diverse, and equitable work environment will improve our probability of success in achieving this vision. We anticipate recruitment for this program in 2025.
Learn more about Sana Scholars.

“The most successful companies recognize that great people hire great people, great people acquire and develop great technologies, and finally, great people attract great capital. Sana’s success is dependent upon attracting and retaining the best people.”
Steve Harr, M.D., President and Chief Executive Officer
NEWS
Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.
This summer, BioSpace will release a series of reports looking at the current state of diversity and inclusion in the life sciences.
Dr. Terry Fry, M.D., a leader in chimeric antigen receptor T-cell (CAR-T) therapies and senior vice president, head of T-cell therapeutics at Sana Biotechnology, will be heading the newly created Gates Institute.
Noubar Afeyan, founder of Flagship Pioneering and Moderna, spoke at an event hosted by the Institute of Global Health Innovation.
Before cell and gene therapy can truly become mainstream medicine, the challenges of allogeneic rejection and targeted delivery must be solved. Sana Biotechnology is on the path to do that.
That’s the advice for emerging growth life sciences companies in 2022, according to attorney Frank Rahmani, partner in the global life science and capital markets practice group at Sidley Austin LLP.
As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.
BioSpace is marking Martin Luther King, Jr. Day by sharing some of our recent coverage about what the life sciences industry is doing to address racial inequality.
Today, Noubar Afeyan, founder of Flagship Pioneering, published the platform development company’s 2022 Annual Letter, and in it, outlined what he sees as the four top forces shaping the future of biotech.
JOBS
IN THE PRESS